Found 18 matching trials
A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1 PHASE3 The purpose of this study is to evaluate the safety and tolerability of TMC...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of TMC435 in Genotype 1, Hepatitis C-infected Patients Who Relapsed After Previous Interferon (IFN)-Based Therapy PHASE3 The purpose of this study is to evaluate the efficacy and safety of TMC435 ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of pegInterferon Alfa-2a, Ribavirin, and Daclatasvir (BMS-790052) With or Without BMS-650032 for Participants in Some Hepatitis C Virus Trials PHASE2 The purpose of this study is to provide anti-hepatitis C virus drugs to pat...
Show More Location
Baptist Medical Center South
Learn More & Join Trial
Effect of Camel Milk on Chronic Hepatitis C PHASE2 Camel milk as the new modality for treatment of chronic hepatitis C. The pu...
Show More Location
Faculty of Traditional Medicine
Learn More & Join Trial
An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Participants PHASE3 The purpose of this study is to investigate the effectiveness and safety of...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3 PHASE3 The purpose of this study is to determine if 24 weeks of treatment with Peg...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen PHASE2 At least 1 dose of pegIFNλ will be identified which is safe, well tolerated...
Show More Location
Advanced Clinical Research Institute
Learn More & Join Trial
A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection PHASE3 The purpose of this study is to evaluate the efficacy, tolerability, and sa...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C PHASE3 The purpose of this study is to compare the sustained virologic response at...
Show More Location
Scti Research Foundation
Learn More & Join Trial
A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients PHASE3 The purpose of this study is to evaluate the efficacy and safety of TMC435 ...
Show More Location
Multiple Locations
Learn More & Join Trial